Search or ask a question

What diagnostics are used to confirm adenocarcinoma?

Endoscopic ultrasound

Answers from top 4 papers

PDF

Open Access

More filters

Papers (4)	Insight
Journal Article•DOI Fine needle aspiration of gastrointestinal stromal tumors. Sherry Q. Li, Timothy J. O’Leary, Sally-Beth Buchner, Ronald M. Przygodzki, Leslie H. Sobin, Yener S. Erozan, Dorothy L. Rosenthal - Show less +6 more 01 Jan 2001-Acta Cytologica 66 Citations	Care must be taken to differentiate epithelioid-type GISTs from adenocarcinoma.
Journal Article•DOI The role of fluorodeoxyglucose and positron emission tomography in the evaluation of pancreatic disease Ashwani Rajput, Thomas A. Stellato, Peter Faulhaber, Hubert Vesselle, Floro Miraldi - Show less +4 more 01 Oct 1998-Surgery 26 Citations	Adenocarcinoma was diagnosed in 9 patients.
Journal Article•DOI The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study Harriet O. Smith, Michael F. Tiffany, Clifford Qualls, Charles R. Key - Show less +3 more 01 Aug 2000-Gynecologic Oncology 638 Citations	These results suggest that current screening practices in the United States are insufficient to detect a significant proportion of adenocarcinoma precursor lesions.
Journal Article•DOI From identification of genomic polymorphism to diagnostic and prognostic markers of human epithelial tumors Eleonora A. Braga, Kiselev Ll, Zabarovskiĭ Er, Zabarovskiĭ Er - Show less +3 more 01 Mar 2004-Molecular Biology 11 Citations	These findings are useful for early diagnostics and post-surgery prognosis of tumors.

My columns

Related Questions

What are current detection methods for kidney cancer?4 answersCurrent detection methods for kidney cancer include imaging techniques, blood tests, liquid biopsy, and urine markers. Imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET)/CT have been used to differentiate between benign and malignant renal masses and predict the response to targeted therapy. Blood tests, specifically the measurement of biomarkers in blood samples, have been explored for the early diagnosis and prognosis of kidney cancer. Liquid biopsy, which involves the analysis of circulating tumor cells, cell-free DNA, RNA, exosomes, and tumor-derived metabolites and proteins, has emerged as a non-invasive method for diagnosis, prognostic assessment, and treatment monitoring. Urine markers have also shown promise in the detection, differentiation, and prognosis of kidney cancer, with studies focusing on microRNAs and proteins as potential urinary biomarkers. These methods aim to improve the early detection and accurate diagnosis of kidney cancer, allowing for timely intervention and personalized treatment approaches.

How is Diagnosis of stomach cancer?5 answersDiagnosis of stomach cancer involves various methods such as endoscopy, terahertz imaging, histopathological analysis, and miRNA expression level detection. Endoscopy is a common method used worldwide for gastric cancer diagnosis, allowing for the detection of abnormalities in the stomach's mucosa. Terahertz imaging is a fast-scanning imaging system that can distinguish cancer tissue from healthy tissue and accurately define the margins of cancer. Histopathological analysis involves examining tissue samples obtained through esophagogastroduodenoscopy or cytologic analysis of gastric wiping/flushing. Detection of altered expression levels of specific miRNAs, such as hsa-miR-484 and hsa-miR-186-5p, in extracellular vesicles can also indicate the presence of gastric cancer. These diagnostic methods aim to improve the detection and characterization of gastric cancer, allowing for earlier intervention and better treatment outcomes.

How accurate is AI at diagnosing cancer?5 answersAI algorithms have shown promising potential in diagnosing cancer, achieving comparable or even superior performance to human experts. In breast cancer diagnosis, an AI system was found to be significantly superior to clinicians in terms of diagnostic accuracy and sensitivity. Several studies have demonstrated the value of AI applications in breast cancer diagnosis, with accuracy being the highest performance metric. In lung cancer diagnosis, an AI system based on deep machine learning showed high accuracy and reliability, with the ability to identify anomalies for human expert review. AI has also been effective in predicting pancreatic cancer using endoscopic ultrasound images, with high accuracy, sensitivity, and specificity. Overall, AI has shown to be accurate in diagnosing cancer, with the potential to improve early detection and patient outcomes.

Is there a blood test that can detect the presence of cancer in early stages?3 answersYes, there are blood tests that can detect the presence of cancer in early stages. One study focused on examining the nonlinear optical characteristics of blood plasma samples to detect cancer. Another study developed an EV-based blood biomarker classifier using EV protein profiles to detect stages I and II pancreatic, ovarian, and bladder cancer. Additionally, a platform called Mercy Halo™ was developed to capture and detect cancer-specific biomarkers on the surface of EVs derived from cancer cells, showing promise for the detection of early-stage ovarian tumors. Aptamer-based electrochemical biosensors have also been explored as a promising approach for the clinical diagnosis of early-stage cancer. These studies demonstrate the potential of blood tests for early cancer detection and highlight the importance of further research and clinical validation.

How long does adenocarcinoma last?5 answers

Who discovered adenocarcinoma?6 answers

See what other people are reading

What is the association between smoking and squamous cell carcinoma of the urinary bladder?

Smoking has a significant association with squamous cell carcinoma (SCC) of the urinary bladder. Studies show that smoking is a primary risk factor for SCCUB, with current smokers having a notably higher risk compared to non-smokers. The relative risk for SCCUB increases with higher tobacco consumption, especially in the highest tertile of pack-years. Additionally, a population-based case-control study in the United States found a strong link between cigarette smoking and SCC of the bladder, with a relative risk of 6.1 among heavy smokers (40 or more cigarettes/day). These findings emphasize the crucial role of smoking as a risk factor for the development of squamous cell carcinoma in the urinary bladder.What are the future research directions concerning HAVCR2 in cancer?

Future research directions concerning HAVCR2 in cancer should focus on several key areas. Firstly, exploring the potential of HAVCR2 as a diagnostic, prognostic, and therapeutic biomarker across various malignancies, particularly in esophageal carcinoma, lung adenocarcinoma, and stomach adenocarcinoma. Secondly, investigating the association between HAVCR2 mutations and clinical manifestations in subcutaneous panniculitis-like T-cell lymphoma (SPTCL) and hemophagocytic lymphohistiocytosis (HLH) patients. Additionally, further studies should delve into the immune modulation role of HAVCR2, its impact on tumor-infiltrating immune cells, especially B cells, and its potential as a target for immunotherapy in cancer, including breast cancer. These research directions could provide valuable insights into leveraging HAVCR2 for improved cancer management strategies.How does the interaction between Socs and IL-10 impact the development and progression of cancer ?

The interaction between SOCS (suppressor of cytokine signaling) and IL-10 plays a crucial role in cancer development and progression. SOCS proteins are key negative regulators of cytokine signaling, including the JAK/STAT pathway. Dysregulation of SOCS expression can lead to constitutive activation of JAK/STAT signaling, promoting oncogenic transformation. In the context of lung cancer, genetic variants of IL-10 have been shown to affect IL-10 production and are associated with disease progression. Additionally, in lung adenocarcinoma, high expression of IL-10 receptor 1 (IL-10R1) by tumor cells is correlated with poor prognosis, indicating that IL-10 signaling may induce cancer cell intrinsic effects that support cancer progression. Therefore, the interplay between SOCS and IL-10 influences cancer pathogenesis by modulating cytokine signaling and immune responses.What are recent studies on Ripretinib?

Recent studies on Ripretinib have shown its efficacy and safety in treating advanced gastrointestinal stromal tumors (GIST). Studies in Chinese patients demonstrated that Ripretinib as a fourth-line treatment resulted in a median progression-free survival (mPFS) of 7.70 months, with manageable adverse events like alopecia and hand-foot syndrome. Another study in Chinese patients receiving Ripretinib as a second-line or later therapy reported a median PFS of 5.9 months and an overall survival of 13.8 months, with primary KIT exon 11 mutations correlating with better outcomes. Furthermore, a phase 3 study is planned to evaluate Ripretinib versus sunitinib in advanced GIST patients with specific KIT mutations, aiming to assess progression-free survival and overall survival. Additionally, long-term follow-up data from a bridging study confirmed the sustained efficacy of Ripretinib in Chinese GIST patients as a fourth-line therapy, with a median PFS of 6.44 months and an overall survival of 25.56 months.Early recurrence ipmn-associated pancreatic cancer?

Early recurrence in IPMN-associated pancreatic cancer is a critical concern for patient management. Studies on resectable pancreatic ductal adenocarcinoma (PDAC) and locally advanced pancreatic cancer (LAPC) provide insights into early recurrence risk factors post-pancreatoduodenectomy and LAPC resection. Factors like tumor size > 4 cm, lymphovascular invasion, and non-hepatopancreatobiliary surgeon involvement are linked to adverse disease-free survival after PDAC resection. In LAPC, early recurrence is associated with poor survival, with predictors including post-induction CA 19-9 levels ≥100 U/mL, poor tumor differentiation, and lack of adjuvant chemotherapy. For pancreatic neuroendocrine tumors (pNETs), tumor size and positive lymph nodes are independent risk factors for early recurrence, emphasizing the need for close monitoring within the first two years post-surgery. These findings underscore the importance of tailored surveillance and treatment strategies for IPMN-associated pancreatic cancer to mitigate early recurrence risks.How does tumor grading correlate with t helper cells?

Tumor grading correlates with the presence and activity of T helper cells in various types of cancer. Studies on renal cell carcinoma (RCC), oral squamous cell carcinoma (OSCC), transitional cell carcinoma (TCC) of the bladder, prostate adenocarcinoma, and cutaneous squamous cell carcinoma (cSCC)have shown significant associations between tumor grades and T helper cell populations. Specifically, higher tumor grades are linked to increased infiltration of regulatory T cells (Tregs) and exhausted CD8 T cells, leading to immune dysfunction and poor prognosis. The immunoscore of T helper cells, especially CD3+ and CD8+ lymphocytes, has been found to decrease with higher tumor grades, indicating a dysregulated immune response in advanced cancers. These findings underscore the importance of considering the immune microenvironment in tumor grading and prognosis.How does excess androgen affect the function of succinate dehydrogenase in female cells?

Excess androgen in female cells can impact succinate dehydrogenase (SDH) function. Research suggests that androgen excess, particularly through activation of the androgen receptor (AR), can lead to systemic oxidative stress. This oxidative stress may contribute to beta-cell failure and insulin resistance, highlighting a potential link between androgen excess and metabolic dysfunction. Additionally, studies indicate that SDH, a crucial enzyme involved in energy production pathways, is regulated differently in various cell types. Furthermore, maternal androgen excess in obese dams affects liver function, with dysregulation of enzymes involved in lipogenesis and fat storage, potentially influencing SDH activity. Therefore, excess androgen can disrupt metabolic function and liver processes, which may indirectly impact SDH function in female cells.What is the correlation between blood group and cancer risk?

The correlation between blood group and cancer risk has been extensively studied. Research indicates that different blood groups may influence the susceptibility to various types of cancer. Studies have shown that individuals with blood group A may have a higher risk of developing cancers such as oral cavity, stomach, pancreas, liver, ovary, cervix, bladder, and breast. On the other hand, blood group O has been associated with a lower risk of colorectal cancer. Additionally, blood group AB has shown a statistically significant relationship with colon cancer compared to blood group O. Furthermore, blood types A and O have been linked to a higher occurrence of breast and lung cancer, while the Rhesus positive blood type is associated with breast cancer and the Rhesus negative blood type with stomach cancer.Does follow up Subsolid pulmonary nodule more than 5 year has clinical benefit ?

Follow-up of subsolid pulmonary nodules (SSNs) for more than 5 years after stability does show clinical benefit. A study found that only 2% of SSNs greater than or equal to 6 mm that were stable for 5 years exhibited subsequent growth, with no clinical impact observed during a median follow-up of 9 years post-stability. SSNs, including pure ground-glass nodules and part-solid nodules, may have indolent clinical courses, but persistent part-solid nodules could be more aggressive than pure ground-glass nodules. Guidelines recommend long-term CT surveillance for SSNs persisting over 3 months, with factors like size, solidity, and number influencing the need for surveillance or surgical intervention. Therefore, extended follow-up of SSNs beyond 5 years can provide valuable clinical insights and aid in determining appropriate management strategies.What are the disparities in cancer metastasis by race?

Significant racial disparities exist in cancer metastasis patterns. Studies reveal that Black patients with lung cancer show varying metastatic site prevalence compared to White patients, with differences in brain, bone, and liver metastasis rates across different types of lung cancer. In metastatic lung adenocarcinoma, Hispanic/Latino patients exhibit lower rates of biomarker testing despite insurance coverage, indicating disparities in testing access. Racial gaps are also evident in the utilization of CDK4/6 inhibitors for metastatic breast cancer, with differences in treatment initiation over time and disparities in CDK4/6 inhibitor uptake between non-Hispanic White and non-Hispanic Black patients. Furthermore, in endometrial cancer, African-Americans have a higher risk of specific metastatic sites compared to Caucasians, emphasizing disparities in metastasis patterns across different histological subtypes. Lastly, Black women with residual ER+ breast cancer exhibit higher TMEM doorway density, potentially contributing to worse distant recurrence-free survival, highlighting racial disparities in metastasis risk.Difficult biliary cannulation in patients with distal malignant biliary obstruction: An underestimated problem?

Difficult biliary cannulation in patients with distal malignant biliary obstruction is a significant challenge. Techniques like the double-guidewire technique (DGT) and precut sphincterotomy are employed to enhance success rates. Despite advancements in endoscopic technologies, predicting difficult cannulation remains challenging. Factors like endoscopist experience and patient anatomy contribute to the complexity. Novel endoscopic modalities like cholangioscopy and intraductal ultrasonography show promise but are not yet routine. In cases of difficult cannulation, endoscopists resort to various techniques such as pancreatic guidewire cannulation and transpancreatic septotomy. Individualized approaches considering endoscopist skill and patient anatomy are crucial for successful outcomes in challenging biliary cannulation scenarios.